Here's Why Momentum in Verona Pharma (VRNA) Should Keep going

Core Viewpoint - The article emphasizes the importance of confirming the sustainability of stock trends for profitable short-term investing, highlighting the need for sound fundamentals and positive earnings estimates to maintain momentum. Group 1: Stock Performance - Verona Pharma PLC (VRNA) has shown a solid price increase of 74.2% over the past 12 weeks, indicating strong investor interest and potential upside [4] - The stock has also increased by 12.5% over the last four weeks, suggesting that the upward trend is still intact [5] - VRNA is currently trading at 94.8% of its 52-week high-low range, indicating a potential breakout [5] Group 2: Fundamental Strength - VRNA holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimate revisions and EPS surprises [6] - The stock has an Average Broker Recommendation of 1 (Strong Buy), reflecting high optimism from the brokerage community regarding its near-term price performance [7] Group 3: Investment Strategy - The "Recent Price Strength" screen is a useful tool for identifying stocks like VRNA that are on an uptrend supported by strong fundamentals [3] - The article suggests that there are several other stocks passing through this screen, indicating potential investment opportunities [8]